Brought to you by 
Forest helps Microbia develop, sell linaclotide in the US
27 Oct 2020
Executive Summary
Microbia (focused on gastrointestinal and cardiovascular therapeutics) and specialty pharma Forest Laboratories will co-develop and co-promote Microbia's linaclotide in the US.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com